We are thrilled to welcome new network members to our community.CTI Life Sciences – A venture capital firm specialized in biotechnology, CTI supports the creation and growth of innovative life sciences companies. Website: www.ctisciences.comMISO Chip – A Montreal-based company developing a tumor-on-a-chip platform that enables anticancer agents to be tested on human tumor tissues while…
CQDM is pleased to announce the advancement of several team members, reflecting their ongoing commitment and contributions to the organization’s mission of supporting collaborative innovation in the life sciences sector. These appointments underscore CQDM’s continued growth and its ability to leverage key talent to strengthen its role as a catalyst between stakeholders across the biopharmaceutical…
Are you driven by innovation, collaboration development, and field work?Are you looking for a role where you can help expand AReNA’s reach, mobilize key players in the RNA ecosystem, and contribute concretely to its growth in Québec and internationally? Discover the role and apply now:
Jasmine Martinelli joined CQDM in May 2026 as an Accounting Technician. In this role, she supports the efficient execution of the organization’s financial operations and contributes to the integrity and reliability of its accounting processes. Prior to joining CQDM, she acquired experience in accounting and financial operations support within both private‑sector and governmental environments. This…
The recent Sweet Pharma Day brought together key players from the life sciences ecosystem at Sucrerie Bonaventure in Mirabel, creating a setting conducive to strategic discussions and meaningful collaborations between Canadian biotechnology companies and global pharmaceutical partners. Co‑organized by CQDM, this annual event serves as a unique platform to showcase excellence in biopharmaceutical innovation while…
A look back at Connect‑Bio at Polytechnique Montréal On April 7, more than 180 participants gathered at Polytechnique Montréal at the initiative of PROTEO and the CQDM for the Connect‑Bio event, united by a shared goal: advancing biofabrication in Québec through collaboration across the ecosystem. The event highlighted the critical role of protein biofabrication in…
On March 26 in Toronto, more than 200 leaders, innovators, investors, and partners from Canada’s genomics and life sciences ecosystem gathered for Connect‑Bio Expanded—an event dedicated to omics technologies and their strategic role in advancing innovation in health and life sciences. This dynamic day was driven by a shared ambition: to foster collaboration, accelerate partnerships,…
CQDM is pleased to launch a call for ideas for the upcoming CQDM Connect-Pharma: Pitch Day, focused on AI-Driven Multi-Omics Integration for Drug Discovery. Selected applicants will present their innovations to experts from CQDM’s global pharmaceutical members on May 28, 2026. Our objective is to bring ground-breaking, innovative Canadian research to CQDM’s pharmaceutical members and…
Discover the story of Epitopea, a biotechnology company specializing in immunotherapy, born from a research project supported by CQDM. Based in Montréal and Cambridge (UK), Epitopea is developing next‑generation therapeutic vaccines. Their goal: to train the immune system to precisely recognize and target tumor‑specific antigens, opening up new possibilities in cancer treatment. From the earliest…
The strategic consortium PROTEO, in collaboration with CQDM, is pleased to announce the upcoming Connect‑BIO – Quebec Forum on Biofabrication, a must‑attend event for researchers, innovators, and life sciences entrepreneurs. This gathering will bring together experts, scientists, and industry leaders to discuss the latest advances, challenges, and opportunities shaping Quebec’s biofabrication ecosystem. What to Expect…